Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850678 · ClinicalTrials.gov registry record · NA
Restoration of Spectral Resolution With Hearing-aid Amplification
A NA study, sponsored by University of Nebraska Lincoln.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT03850678 is a NA study that has completed, run by University of Nebraska Lincoln. The registered enrollment target is 209 participants.
The verdict
NCT03850678, a NA study, has completed, sponsored by University of Nebraska Lincoln.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The objective of this study protocol is to determine the efficacy of using aided measures of spectral resolution to set the dynamic range of hearing with hearing-aid amplification. Measures of spectral resolution will be obtained, as will measures of speech recognition.
Interventions
- DEVICE Hearing Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03850678
The ClinicalTrials.gov registry entry for NCT03850678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska Lincoln, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hearing Aid is the first listed.
NCT03850678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03850678 about?
NCT03850678 is a clinical study titled "Restoration of Spectral Resolution With Hearing-aid Amplification". The objective of this study protocol is to determine the efficacy of using aided measures of spectral resolution to set the dynamic range of hearing with hearing-aid amplification. Measures of spectral resolution will be obtained, as will measures of speech recognition.
What is the current status of trial NCT03850678?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2019-04-02. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT03850678?
The interventions under investigation include: Hearing Aid (DEVICE).
Who is sponsoring clinical trial NCT03850678?
This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.